Watchlist Price Alert

Vertex Inc. (VERX)

NASDAQ: VERX · Real-Time Price · USD

39.51

-0.03 (-0.08%)

At close: May 29, 2025, 3:59 PM

39.51

0.00%

After-hours: May 29, 2025, 04:04 PM EDT

-0.08% (1D)

Bid	38
Market Cap	6.26B
Revenue (ttm)	687.06M
Net Income (ttm)	-44.28M
EPS (ttm)	-0.29
PE Ratio (ttm)	-136.24
Forward PE	50.03
Analyst	Buy

Ask	40.58
Volume	531,465
Avg. Volume (20D)	1,261,088
Open	39.74
Previous Close	39.54
Day's Range	39.02 - 39.82
52-Week Range	30.26 - 60.71
Beta	0.78

About VERX

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol VERX

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for VERX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Why Price Moved

3 weeks ago

+0.21%

VERX stock has given up its prior gain. Vertex sha... Unlock content with Pro Subscription

3 weeks ago

+0.21%

Vertex shares are trading higher after the company reported better-than-expected Q1 financial results.

News

6 days ago · seekingalpha.com

Vertex: Continuing To Dominate In CF, But What About Its Pain Pipeline?

Vertex Pharmaceuticals Incorporated remains a buy despite recent share price weakness, supported by its dominant cystic fibrosis franchise and robust late-stage pipeline. Alyftrek's launch extends Ver...

2 weeks ago · businesswire.com

Vertex to Participate in Upcoming Investor Conferences

BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced management participation in three upcoming investor conferences. Susie Lisa, Senior Vice President, Investor...

3 weeks ago · youtube.com

Final Trades: Vertex Pharma, Palantir, Wynn Resorts and Microsoft

The Investment Committee give you their top names to watch for the second half.

3 weeks ago · seekingalpha.com

Vertex, Inc. (VERX) Q1 2025 Earnings Call Transcript

Vertex, Inc. (NASDAQ:VERX ) Q1 2025 Earnings Conference Call May 7, 2025 8:30 AM ET Company Participants Joe Crivelli - Vice President of Investor Relations David DeStefano - President and Chief Execu...

3 weeks ago · zacks.com

Compared to Estimates, Vertex (VERX) Q1 Earnings: A Look at Key Metrics

The headline numbers for Vertex (VERX) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates...

3 weeks ago · zacks.com

Vertex (VERX) Q1 Earnings and Revenues Top Estimates

Vertex (VERX) came out with quarterly earnings of $0.15 per share, beating the Zacks Consensus Estimate of $0.13 per share. This compares to earnings of $0.15 per share a year ago.

3 weeks ago · fool.com

Why Vertex Pharmaceuticals Stock Is a Screaming Buy on the Dip

Vertex Pharmaceuticals' (VRTX -9.39%) remarkable momentum came to a screeching halt this week. The big biotech stock had been up well over 20% year to date.

3 weeks ago · seekingalpha.com

Vertex On Track To Significantly Improve Revenue And Earnings By 2030

Vertex Pharmaceuticals reported decent Q1 earnings, but the company missed estimates for both revenue and earnings. Vertex's diversification efforts are most visible in the progress of its pain manage...